Search Results - "Ashwath Narayana, D H"

Rabies encephalitis in a preschool child following postexposure prophylaxis by Chaitra, K M, Ballal, Sandeep, Masthi, N R Ramesh, Ashwath Narayana, D H, Yashodha, H T, Kumar, Mansi, Asiya, Afroza, Bharathi G, Divya, S C, Sanjay

“…We report a case of rabies encephalitis in a 4½-year-old male child with an exposure to a suspect rabid dog. The child developed rabies 25 days after receiving…”
Get full text

Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey by Sudarshan, M.K, Madhusudana, S.N, Mahendra, B.J, Rao, N.S.N, Ashwath Narayana, D.H, Abdul Rahman, S, Meslin, F.-X, Lobo, D, Ravikumar, K, Gangaboraiah

“…Summary Objective Human rabies has been endemic in India since time immemorial, and the true incidence of the disease and nationwide epidemiological factors…”
Get full text

Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study by Gogtay, Nithya J, Munshi, Renuka, Ashwath Narayana, D H, Mahendra, B J, Kshirsagar, Vikas, Gunale, Bhagwat, Moore, Susan, Cheslock, Peter, Thaker, Saket, Deshpande, Siddharth, Karande, Sunil, Kumbhar, Dipti, Ravish, H S, Harish, B R, Pisal, Sambhaji S, Dhere, Rajeev, Parulekar, Varsha, Blackwelder, William C, Molrine, Deborah C, Kulkarni, Prasad S

“…Lack of access to rabies immunoglobulin (RIG) contributes to high rabies mortality. A recombinant human monoclonal antibody (SII RMAb) was tested in a…”
Get full text

Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures by Haradanhalli, Ravish S., Fotedar, Nidhi, Kumari, Nitu, Narayana, D. H. Ashwath

“…The human rabies immunoglobulin (HRIG) is a life-saving immune biological essential for all category III animal exposures. It provides neutralizing antibodies…”
Get full text

Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures - an exploratory study by Haradanhalli, Ravish S., Kumari, Nitu, Sudarshan, Mysore K., Narayana, D. H. Ashwath, Prashanth, Ramya M., Surendran, Jithin

“…WHO recommends infiltration of rabies immunoglobulins/rabies monoclonal antibodies as anatomically possible, into or close to all category III animal bite…”
Get full text

Rabies: A Model for One Health Success by D. H. Ashwath Narayana

Get full text

Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen) by Mahendra, BJ, Narayana, DH Ashwath, Agarkhedkar, Sharad, Ravish, HS, Harish, BR, Agarkhedkar, Shalaka, Madhusudana, SN, Belludi, Ashwin, Ahmed, Khaleel, Jonnalagedda, Rekha, Vakil, Hoshang, Bhusal, Chiranjiwi, Arora, Ashwani Kumar

“…Despite availability of effective rabies vaccines, India has the highest global mortality rate for rabies. Low socio-economic communities are most affected due…”
Get full text

Is the skin sensitivity test required for administering equine rabies immunoglobulin? by Sudarshan, M K, Ashwath Narayana, D H, Ravish, H S

“…Rabies immunoglobulins are life-saving in patients with severe exposure to rabies. Despite the high degree of purification of equine rabies immunoglobulin…”
Get full text

A survey of hospitals managing human rabies cases in India by Sudarshan, M K, Ashwath Narayana, D H

“…A survey of 23 infectious diseases (ID) hospitals/ID wards of general hospitals was done during 2008-09 to assess the facilities for and management of rabies…”
Get full text

Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India by Sudarshan, M.K., Madhusudana, S.N., Mahendra, B.J., Ashwath Narayana, D.H., Ananda Giri, M.S., Popova, O., Vakil, H.B.

“…Human rabies is an ongoing significant public health problem inmany developing countries, with India reporting the highest incidence of rabies-related deaths…”
Get full text

Assessing the Safety of Post-exposure Rabies Immunization in Pregnancy by Sudarshan, Mysore Kalappa, Ananda Giri, M.S., Mahendra, Bangalore J., Venkatesh, G.M., Sanjay, Thitamaranahalli V., Ashwath Narayana, D.H., Ravish, H.S.

“…Fourteen pregnant women who received rabies post-exposure prophylaxis (PEP) at the anti-rabies clinic (ARC) of Kempegowda Institute of Medical Sciences (KIMS)…”
Get full text

Evaluation of a new premedication protocol for administration of equine rabies immunoglobulin in patients with hypersensitivity by Sudarshan, M K, Kodandaram, N S, Venkatesh, G M, Mahendra, B J, Ashwath Narayana, D H, Parasuramalu, B G

“…The present study was undertaken to standardize skin testing and to develop a safe and effective premedication protocol for administration of ERIG in those…”
Get full text

Assessing the immunogenicity of pre-exposure rabies prophylaxis and interchangeability of booster doses in a cohort of high-risk individuals by Masthi, N. R. Ramesh, Narayana, D. H. Ashwath, Mani, Reeta S., Anwith, H. S., Manjunatha, V., Ashwini, M. A., Kiruffi, Vinitha, Reddy, Deekshith J., Lavanya, R.

Get full text

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study by Kulkarni, Prasad S., Kadam, Abhijit, Godbole, Sheela, Bhatt, Varsha, Raut, Abhishek, Kohli, Sunil, Tripathi, Santanu, Kulkarni, Praveen, Ludam, Rakhi, Prabhu, Madhav, Bavdekar, Ashish, Gogtay, Nithya J., Meshram, Sushant, Kadhiravan, Tamilarasu, Kar, Sonali, Narayana, D.H. Ashwath, Samuel, Clarence, Kulkarni, Govind, Gaidhane, Abhay, Sathyapalan, Dipu, Raut, Sidram, Hadda, Vijay, Bhalla, Hira Lal, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Plested, Joyce S., Cloney-Clarke, Shane, Zhu, Mingzhu, Pryor, Melinda, Hamilton, Stephanie, Thakar, Madhuri, Shete, Ashwini, Gautam, Manish, Gupta, Nivedita, Panda, Samiran, Shaligram, Umesh, Poonawalla, Cyrus S., Bhargava, Balram, Gunale, Bhagwat, Kapse, Dhananjay, Kanitkar, Shubhangi A., Kakrani, Arjun L., Tripathy, Srikanth P., Tilak, Abhijit V., Dhamne, Akshay A., Mirza, Shahzad Beg, Athavale, Prachi V., Bhowmik, Mandakini, Ratnakar, Parag J., Gupta, Subodh, Deotale, Vijayshri, Jain, Jyoti, Kalantri, Ashwini, Jain, Vineet, Goyal, Nidhi, Arya, Alok, Rongsen-Chandola, Temsunaro, Dasgupta, Shreyasi, Periera, Pratibha, A, Vanmathi, Kawade, Anand, Gondhali, Arunkumar, Kudyar, Palvi, Singh, Abhishek, Yadav, Ravi, Alexander, Alina, Gunasekaran, Venugopalan, Dineshbabu, Sekar, Samantaray, P.C., Ravish, H.S., Kamra, Deepshikha, Gaidhane, Shilpa, Zahiruddin, Quazi Syed, Moni, Merlin, Kumar, Anil, Dravid, Ameet, Mohan, Anant, Suri, Tejas, Patel, Tejas K., Kishore, Surekha, Choche, Rahul, Ghatage, Deepak, Salvi, Sugam

“…NVX-CoV2373, a Covid-19 vaccine was developed in the USA with ∼90% efficacy. The same vaccine is manufactured in India after technology transfer (called as…”
Get full text

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study by Hampson, Katie, Ventura, Francesco, Steenson, Rachel, Mancy, Rebecca, Trotter, Caroline, Cooper, Laura, Abela-Ridder, Bernadette, Knopf, Lea, Ringenier, Moniek, Tenzin, Tenzin, Ly, Sowath, Tarantola, Arnaud, Moyengar, Ronelngar, Oussiguéré, Assandi, Bonfoh, Bassirou, Narayana, DH Ashwath, Sudarshan, Mysore Kalappa, Muturi, Matthew, Mwatondo, Athman, Wambura, Gati, Andriamandimby, Soa Fy, Baril, Laurence, Edosoa, Glenn T, Traoré, Abdallah, Jayme, Sarah, Kotzé, Johann, Gunesekera, Amila, Chitnis, Nakul, Hattendorf, Jan, Laager, Mirjam, Lechenne, Monique, Zinsstag, Jakob, Changalucha, Joel, Mtema, Zac, Lugelo, Ahmed, Lushasi, Kennedy, Yurachai, Onphirul, Metcalf, Charlotte Jessica E., Rajeev, Malavika, Blanton, Jesse, Costa, Galileu Barbosa, Sreenivasan, Nandini, Wallace, Ryan, Briggs, Deborah, Taylor, Louise, Thumbi, Samuel M., Huong, Nguyen Thi Thanh

“…Tens of thousands of people die from dog-mediated rabies annually. Deaths can be prevented through post-exposure prophylaxis for people who have been bitten,…”
Get full text

An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey by Sudarshan, M K, Mahendra, B J, Madhusudana, S N, Ashwoath Narayana, D H, Rahman, Abdul, Rao, N S N, X-Meslin, F, Lobo, Derek, Ravikumar, K, Gangaboraiah

“…This was a WHO sponsored national multi-centric rabies survey and one of its objectives was to find out the incidence of animal bites, anti-rabies treatment…”
Get more information

A Study on Clinical Features and Cost Incurred by Dengue Syndrome Patients Admitted to A Tertiary Care Hospital by Sathish Chandra MR, Ashwath Narayana DH, Manjunath M

“…Introduction: Dengue infections are a significant cause of morbidity and mortality which leads to adverse economic effects in many developing tropical…”
Get full text

Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa by Sudarshan, M K, Madhusudana, S N, Mahendra, B J, Narayana, D H Ashwath, Giri, M S Ananda, Muhamuda, K, Ravish, H S, Venkatesh, G M

“…At present, in the event of re-exposure to rabies, 2 booster doses are recommended for people who have been previously vaccinated with cell culture rabies…”
Get full text

Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis by Sudarshan, M K, Mahendra, B J, Madhusudana, S N, Narayana, D H Ashwath, Sanjay, T V, Gangaboraiah, Anandagiri, M S

“…A meta-analysis was done to study the relationship between antigenecity and immunogenecity of human rabies vaccines. The data of ten cell culture human rabies…”
Get full text